secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2023-11-14T23:59:59+00:00
Accession:  0001213900-23-087126
Event type: leadership
Sentiment:  positive
Materiality: 0.55
Item codes: 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne appoints medtech exec Christopher Volker as COO; inducement plan expanded by 420,350 shares
--------------------------------------------------------------------------------

- Christopher Volker appointed COO effective Nov 10, 2023; formerly Head of Commercial Integration at Abbott and VP/GM International at Cardiovascular Systems.
- Volker receives base salary of $288,000, 40% target bonus, and option to purchase 324,560 shares at $1.32 per share.
- Inducement plan amended to increase reserved shares from 150,000 to 570,350 to attract qualified employees.
- Option vests 25% after one year, then monthly over 36 months; accelerated vesting upon change in control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390023087126/0001213900-23-087126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390023087126/ea188259-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-087126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer